HKSE:01612 (Hong Kong)
Â
Shs Reg S
HK$
0.38
(0%)
Apr 24
What is a stock summary page? Click here for an overview.
Business Description
Vincent Medical Holdings Ltd
NAICS : 334510
SIC : 3842
ISIN : KYG9367D1025
Share Class Description:
HKSE:01612: Shs Reg SCompare
Compare
Traded in other countries / regions
01612.Hong Kong IPO Date
2016-07-13Description
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer requirement. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under Inspired Medical, Hand of Hope, and Hypnus brands. Its product categories include Respiratory products, Imaging disposable products, Orthopaedic and rehabilitation products, and Others. Its geographical segments are United States, The PRC, Japan, Costa Rica, The Netherlands, Spain, Germany, Hong Kong, Turkey, Canada, India, Thailand, Vietnam and Others.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.74 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 1.26 | |||||
Interest Coverage | 58.35 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.03 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.4 | |||||
3-Year EBITDA Growth Rate | -30.7 | |||||
3-Year EPS without NRI Growth Rate | -35.8 | |||||
3-Year FCF Growth Rate | -24.2 | |||||
3-Year Book Growth Rate | -4.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.97 | |||||
9-Day RSI | 34.97 | |||||
14-Day RSI | 38.84 | |||||
3-1 Month Momentum % | 21.79 | |||||
6-1 Month Momentum % | 10.47 | |||||
12-1 Month Momentum % | 25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.16 | |||||
Quick Ratio | 1.56 | |||||
Cash Ratio | 0.64 | |||||
Days Inventory | 113.98 | |||||
Days Sales Outstanding | 76.73 | |||||
Days Payable | 33.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 8.16 | |||||
Dividend Payout Ratio | 0.29 | |||||
3-Year Dividend Growth Rate | 5.7 | |||||
Forward Dividend Yield % | 8.95 | |||||
5-Year Yield-on-Cost % | 12.67 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 12.5 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 32.46 | |||||
Operating Margin % | 9.92 | |||||
Net Margin % | 8.64 | |||||
FCF Margin % | 6.34 | |||||
ROE % | 12.31 | |||||
ROA % | 8.27 | |||||
ROIC % | 14.12 | |||||
3-Year ROIIC % | 136.22 | |||||
ROC (Joel Greenblatt) % | 22.91 | |||||
ROCE % | 13.44 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.55 | |||||
PE Ratio without NRI | 3.55 | |||||
Shiller PE Ratio | 4.22 | |||||
Price-to-Owner-Earnings | 3.11 | |||||
PEG Ratio | 2.37 | |||||
PS Ratio | 0.3 | |||||
PB Ratio | 0.43 | |||||
Price-to-Tangible-Book | 0.44 | |||||
Price-to-Free-Cash-Flow | 4.87 | |||||
Price-to-Operating-Cash-Flow | 2 | |||||
EV-to-EBIT | 2.26 | |||||
EV-to-EBITDA | 2.26 | |||||
EV-to-Revenue | 0.22 | |||||
EV-to-FCF | 3.47 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Projected-FCF | 0.24 | |||||
Price-to-Graham-Number | 0.26 | |||||
Price-to-Net-Current-Asset-Value | 1 | |||||
Earnings Yield (Greenblatt) % | 44.25 | |||||
FCF Yield % | 20.46 | |||||
Forward Rate of Return (Yacktman) % | 25.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vincent Medical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 800.963 | ||
EPS (TTM) (HK$) | 0.107 | ||
Beta | 0.62 | ||
3-Year Sharpe Ratio | -0.18 | ||
3-Year Sortino Ratio | -0.26 | ||
Volatility % | 39 | ||
14-Day RSI | 38.84 | ||
14-Day ATR (HK$) | 0.017745 | ||
20-Day SMA (HK$) | 0.429 | ||
12-1 Month Momentum % | 25 | ||
52-Week Range (HK$) | 0.355 - 0.55 | ||
Shares Outstanding (Mil) | 653.34 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vincent Medical Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vincent Medical Holdings Ltd Stock Events
Event | Date | Price (HK$) | ||
---|---|---|---|---|
No Event Data |
Vincent Medical Holdings Ltd Frequently Asked Questions
What is Vincent Medical Holdings Ltd(HKSE:01612)'s stock price today?
The current price of HKSE:01612 is HK$0.38. The 52 week high of HKSE:01612 is HK$0.55 and 52 week low is HK$0.36.
When is next earnings date of Vincent Medical Holdings Ltd(HKSE:01612)?
The next earnings date of Vincent Medical Holdings Ltd(HKSE:01612) is .
Does Vincent Medical Holdings Ltd(HKSE:01612) pay dividends? If so, how much?
The Dividend Yield %  of Vincent Medical Holdings Ltd(HKSE:01612) is 8.16% (As of Today), Highest Dividend Payout Ratio of Vincent Medical Holdings Ltd(HKSE:01612) was 0.99. The lowest was 0.03. And the median was 0.44. The  Forward Dividend Yield % of Vincent Medical Holdings Ltd(HKSE:01612) is 8.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |